These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Management of a case of neuroleptic malignant syndrome with bromocriptine. Zubenko G; Pope HG Am J Psychiatry; 1983 Dec; 140(12):1619-20. PubMed ID: 6650696 [TBL] [Abstract][Full Text] [Related]
28. [A cocaine-induced variant of the neuroleptic malignant syndrome. A case study]. Smidt MH; Collumbien EC Tijdschr Psychiatr; 2006; 48(5):399-404. PubMed ID: 16956032 [TBL] [Abstract][Full Text] [Related]
29. Management of neuroleptic malignant syndrome--a series of eight cases. Kurien T; Rajeev KK; Abraham OC; Archana S; Cherian AM J Assoc Physicians India; 1993 Feb; 41(2):91-3. PubMed ID: 8101521 [TBL] [Abstract][Full Text] [Related]
30. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation. Mendhekar DN; Jiloha RC Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023 [No Abstract] [Full Text] [Related]
34. Possible neuroleptic malignant syndrome associated with olanzapine. Nyfort-Hansen K; Alderman CP Ann Pharmacother; 2000 May; 34(5):667. PubMed ID: 10852098 [No Abstract] [Full Text] [Related]
35. Neuroleptic malignant syndrome: two cases without muscle rigidity. Wong MM Aust N Z J Psychiatry; 1996 Jun; 30(3):415-8. PubMed ID: 8839955 [TBL] [Abstract][Full Text] [Related]